TIME SAVINGS WITH Q4W (ONCE-MONTHLY) C.E.R.A.- A TIME AND MOTION STUDY CONDUCTED IN HAEMODIALYSIS CENTRES IN FIVE EUROPEAN COUNTRIES
Author(s)
Raluy M1, Irgl H2, De Cock E11United BioSource Corporation, Barcelona, Spain, 2F. Hoffmann-La Roche Ltd., Basel, Switzerland
Presentation Documents
BACKGROUND: Governments across Europe are increasingly focused on controlling rising health care costs. Within this context, a major challenge for haemodialysis centres is to maximise efficiencies while maintaining high standards of care. OBJECTIVES: The aim of this study was to document health care personnel time for anaemia management in maintenance therapy for both shorter-acting erythropoiesis-stimulating agents (ESA) and a continuous erythropoiesis receptor activator (C.E.R.A.) once monthly (Q4W), and model time savings following the introduction of Q4W C.E.R.A. in five European countries. METHODS: A multinational, multicentre time and motion study has been conducted in 16 centres across Germany, France, Italy, Poland and Spain. The time spent on frequent anaemia management-related tasks (preparation, distribution, injection, record-keeping) was recorded in each centre by trained observers. Time/pt/session was used to calculate time/pt/year, time/centre/year and for modelling potential time savings with a 100% uptake of C.E.R.A. RESULTS: Numbers of ESA injections/pt/year, weighted by type of ESA, frequency and route of administration, ranged from 53-148. The mean uptake of C.E.R.A. Q4W across 16 centres was 29% (7-56%). The mean annual reduction in the number of ESA administrations following conversion to C.E.R.A. was 76 (41-136). Estimated observed time/pt/year ranged from 38-310 min for ESA and 6-68 min for C.E.R.A. Assuming a 100% uptake of Q4W C.E.R.A. maintenance therapy, annual time savings/centre for frequent anaemia management tasks would be 84% (79-91%) in Germany, 78% (74-86%) in France, 88% (87-88%) in Italy, 85% (78-88%) in Poland and 77% (69-84%) in Spain. CONCLUSIONS: Substantial annual time savings on frequent anaemia management-related tasks were consistently found in haemodialysis centres across five European countries with a 100% uptake of Q4W C.E.R.A. maintenance therapy. This provides the opportunity to re-focus health care resources, at a critical time point in the dialysis procedure, on other important CKD care tasks in order to improve overall pt care.
Conference/Value in Health Info
2010-11, ISPOR Europe 2010, Prague, Czech Republic
Value in Health, Vol. 13, No. 7 (November 2010)
Code
PUK27
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Work & Home Productivity - Indirect Costs
Disease
Urinary/Kidney Disorders